Skip to content

Author

S. Bravo-López

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Dual Role of Cx43 in Enhancing CDK4/6 Inhibitor Response and Promoting the Elimination of Therapy-Induced Senescent Tumor Cells

Breast cancer has become the most prevalent malignancy worldwide. A key clinical advance has been the introduction of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i), that in combination with endocrine therapy has been a major advance for the treatment of luminal (ER⁺/HER2⁻) breast cancer. CDK4/6i induce cell cycle ar...

P. Carpintero-Fernández, Marta Barturen-Gómez, Vanesa Alvarez et al. · 0 citations
Open access Oct 2026

Profiling STEMI: improving prognosis through proteomic analysis

The aftermath that acute myocardial infarction patients have to face is one that includes significant clinical repercussions that affect their quality of life. Our objetive was to identify circulating proteomic biomarkers that characterize and improve the prognosis of ST-segment elevation myocardial infarction (STEMI...

S. R. Moar, S. Bravo-López, C. Neiro-Rey et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.